QSAM Biosciences, Inc.: auditor change — QSAM Biosciences appoints Assurance Dimensions as new auditor, dismisses D. Brooks

QSAM Biosciences, Inc.

Audit Committee appointed Assurance Dimensions as independent registered public accounting firm for fiscal year ending Dec 31, 2023, effective May 12, 2023.
Dismissed D. Brooks and Associates as prior auditor; no adverse opinions or disagreements in prior two fiscal years.
No reportable events or disagreements occurred during 2021, 2022, or interim 2023 period.
Company furnished D. Brooks' letter of agreement with disclosures as Exhibit 16.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

QSAM Biosciences, Inc. engaged Assurance Dimensions, Inc. as its auditor.

Action: engagement
Auditor: Assurance Dimensions, Inc.

Exact text from the filing

On May 12, 2023, the Audit Committee of the Board of Directors of QSAM Biosciences, Inc. (the “Company”) appointed Assurance Dimensions, Inc. (“Assurance Dimensions”) as our independent registered public accounting firm for the fiscal year ending December 31, 2023, subject to normal and customary client engagement procedures.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

QSAM Biosciences, Inc. dismissed D. Brooks and Associates, CPAs, P.A. as its auditor.

Action: dismissal
Auditor: D. Brooks and Associates, CPAs, P.A.
Successor: Assurance Dimensions, Inc.

Exact text from the filing

On the same day, the Audit Committee dismissed D. Brooks and Associates, CPAs, P.A. (“D. Brooks”) as our independent registered public accounting firm.

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001493152-23-016673

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.